NasdaqGS:TXGLife Sciences
Assessing 10x Genomics (TXG) Valuation After Flat 2026 Guidance And Improved Losses
What the latest earnings and guidance mean for 10x Genomics (TXG)
10x Genomics (TXG) just paired its fourth quarter and full year 2025 results with new 2026 revenue guidance. This gives investors fresh data on growth, profitability and how management is framing the year ahead.
See our latest analysis for 10x Genomics.
10x Genomics shares are at US$19.10, with a 1 day share price return of 1.11% and a 7 day share price return of 2.58%. The 30 day share price return shows a 14.66% decline,...